Christopher Gibson - Feb 7, 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Feb 7, 2024
Transactions value $
-$367,481
Form type
4
Date filed
2/9/2024, 05:34 PM
Previous filing
Jan 5, 2024
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +10K +1.26% $0.00 802K Feb 7, 2024 Direct F1, F2
transaction RXRX Class A Common Stock Gift $0 -10K -1.25% $0.00 792K Feb 7, 2024 Direct F1
transaction RXRX Class A Common Stock Options Exercise $77.5K +31.3K +3.95% $2.48 823K Feb 7, 2024 Direct F1
transaction RXRX Class A Common Stock Sale -$445K -48.3K -5.87% $9.22 775K Feb 7, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -31.3K -8.33% $0.00 344K Feb 7, 2024 Class A Common Stock 31.3K $2.48 Direct F1, F6
transaction RXRX Class B Common Stock Conversion of derivative security $0 -10K -0.15% $0.00 6.47M Feb 7, 2024 Class A Common Stock 10K $0.00 Direct F1, F7, F8
holding RXRX Stock Option (Right to Buy) 814K Feb 7, 2024 Class A Common Stock 0 $8.55 Direct F4
holding RXRX Stock Option (Right to Buy) 5.44K Feb 7, 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 408K Feb 7, 2024 Class A Common Stock 0 $11.40 Direct F5
holding RXRX Class B Common Stock 515K Feb 7, 2024 Class A Common Stock 0 $0.00 by LAHWRAN-3 LLC F8, F9
holding RXRX Class B Common Stock 408K Feb 7, 2024 Class A Common Stock 0 $0.00 by LAHWRAN-4 LLC F8, F10
holding RXRX Class B Common Stock 119K Feb 7, 2024 Class A Common Stock 0 $0.00 by Gibson Family Trust F8, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022.
F2 Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person
F3 This transaction was executed in multiple trades at prices ranging from $9.07 to $9.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F6 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F7 Represents the conversion of Class B Common Stock into Class A Common Stock.
F8 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F9 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F11 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.